BROOKS LABORATORIES Share Price

BROOKS LABORATORIES Share Price

NSE: BROOKS
|
Pharmaceuticals
|
S Cap
₹ 60.82
+₹1.73 (2.93%)
1D
Last updated 23 Sep, 2026, 10:36 IST

BROOKS LABORATORIES Share Price Today

As of 23 Sep 2026, BROOKS LABORATORIES share price is ₹60.82. The stock opened at ₹60.74, compared to its previous close of ₹59.09. During today's trading session, BROOKS LABORATORIES share price moved in the range of ₹59.09 to ₹61.11, with an average price of ₹60.10 for the day. Looking at its last 52-week, the stock has touched a low of ₹36.30 and a high of ₹153.99. On the performance front, BROOKS LABORATORIES share price has increased by 12.25% over the last six months and is down 59.82% on a year-on-year basis.

₹59.09
2.93% up today
₹61.11
1D LOW
1D HIGH

BROOKS LABORATORIES Returns Calculator

Circuit
L
H
₹53.19
₹64.99
52-week
L
H
₹36.30
₹153.99

About BROOKS LABORATORIES

BROOKS LABORATORIES Share Price
ISIN
INE650L01011
Sector Market Cap
₹ 174.74 Cr

Brooks Laboratories Limited is an India-based pharmaceutical manufacturing company working on a contract basis. The Company’s segment is Pharmaceutical products, including ingredients and intermediaries. It manufactures various pharmaceutical dosage forms, including injections, tablets, dry syrup, and eye/ear drops. Its products under the Carbapenem category are Imipenem 250 (Milligram) mg + Cilastatin 250mg, Imipenem 500mg + Cilastatin 500mg, Meropenem 250mg, Meropenem 500mg, Meropenem 1000mg+Sulbactam 500mg, Meropenem 1000mg+Tazobactam 500mg, and Doripenem 500mg. It offers Penicillins in the form of injections, tablets, and dry syrup. Its general category of products includes liquid injections, dry powder injections and eye/ear drops. Its liquid injections include Iron sucrose 100mg/5ml, Iron sucrose 50mg/2.5ml, Phenytoin sodium 50mg/ml and others. Its dry powder injections include Artesunate 60mg, Artesunate 120mg, Omeprazole 40mg, Rabeprazole 20mg, Pantoprazole 40mg and others.

BROOKS LABORATORIES Financial Highlights

  • Revenue: BROOKS LABORATORIES reported revenue of ₹86.91 crore in FY26 vs ₹83.44 crore in FY25. It showed an increase of 4.16% on a yearly basis.
  • Operating Profit: BROOKS LABORATORIES reported an operating profit of ₹24.58 crore in FY26 vs ₹9.79 crore in FY25. It showed an increase of 351.07% on a year-on-year basis.
  • Net Profit: BROOKS LABORATORIES reported a net profit of ₹24.58 crore in FY26 vs ₹9.97 crore in FY25. It showed an increase of 346.54% on a yearly basis.

BROOKS LABORATORIES Quarterly Result Highlights

  • BROOKS LABORATORIES reported revenue of ₹23.14 crore in Jun 2026, compared with ₹20.65 crore in Mar 2026, representing an increase of 12.06% on a quarter-on-quarter (QoQ) basis.
  • BROOKS LABORATORIES reported an operating loss of ₹1.79 crore in Jun 2026, compared with ₹1.52 crore in Mar 2026, representing a decrease of 217.76% on a quarter-on-quarter (QoQ) basis.
  • BROOKS LABORATORIES reported a loss of ₹1.79 crore in Jun 2026, compared with ₹1.52 crore in Mar 2026, reflecting a decrease of 217.76% on a QoQ basis.
  • The earnings per share (EPS) of BROOKS LABORATORIES stood at ₹8.35 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
52.62%
FII
0.00%
Other DII
0.48%
Retail and other
37.00%
Mutual funds
9.90%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.01%
Dec 20250.09%
Mar 20260.17%
Jun 20260.00%
Mkt Cap Cr
175.12
P/E
13.24
P/B
1.43
ROE
20.04%
D/E
0.07
ROCE
19.30%
Div. Yield
0.00%
EPS(TTM)
1.97
Turnover
0.57
EV/EBITDA
11.26
Net Margin
6.78%
Op. Margin
9.60%
ROA
8.92%
Quick Ratio
1.21
Curr. Ratio
2.43
Based on fundamentals, this stock's
Step 4 of 5
Performance
Good
Brooks Lab. outperforming most market indices
Step 1 of 5
Valuation
Overvalued
Brooks Lab. appears overvalued compared to its peers
Step 4 of 5
Earnings
Good
Brooks Lab. revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,48,196.0036.515.2913.74%0.6117.33%93.240.86%0.4810.90
Divis Laboratories2,50,390.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,88,967.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,810.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,888.0033.253.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,00,364.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,00,329.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma98,803.9026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

BROOKS LABORATORIES Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹85.74₹82.56₹79.49₹63.20
Other Income₹1.17₹0.88₹0.92₹0.21
Total Revenue₹86.91₹83.44₹80.40₹63.42
Total Expenses₹81.10₹80.25₹78.85₹98.83
Profit Before Tax₹24.58-₹9.79-₹19.57-₹38.37
Tax₹0.00₹0.18₹0.03-₹7.32
Profit After Tax₹24.58-₹9.97-₹19.59-₹31.05
EPS - Basic₹8.35-₹3.72-₹7.67-₹12.57
EPS - Diluted₹8.35-₹3.72-₹7.67-₹12.57

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹24.58-₹9.79-₹19.57-₹38.37
Income before WC changes₹7.45₹4.64₹3.08-₹25.76
Change in Assets₹2.51-₹1.71-₹3.78-₹0.33
Change in Liabilities-₹0.73-₹0.81-₹9.29₹11.76
Change in WC₹1.78-₹2.52-₹13.08₹11.43
Cash flow from Operations₹9.29₹2.63-₹9.80-₹14.49
Cash flow from Investing-₹2.92-₹45.14₹0.18₹0.49
Cash flow from Financing₹0.17₹42.43₹9.72₹11.41
Total Cash Flow₹6.54-₹0.08₹0.10-₹2.58
Cash (Start of the year)₹0.04₹0.13₹0.02₹2.61
Cash (End of the year)₹6.59₹0.04₹0.13₹0.02

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹110.76₹89.82₹59.40₹81.99
Current Assets₹37.42₹33.88₹31.05₹27.61
Total Assets₹148.17₹123.69₹90.45₹109.60
Current Liabilities₹21.81₹22.84₹23.05₹33.02
Net Current Asset₹15.60₹11.03₹8.00-₹5.42
Non-Current Liabilities₹3.70₹2.75₹1.81₹2.62
Equity Capital₹122.66₹98.10₹65.59₹73.95
Total Equity & Liabilities₹148.17₹123.69₹90.45₹109.60

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹85.74₹82.56₹79.49₹55.54
Other Income₹1.17₹0.88₹0.92₹0.12
Total Revenue₹86.91₹83.44₹80.40₹55.65
Total Expenses₹81.10₹80.21₹78.85₹63.84
Profit Before Tax₹5.81₹3.23₹1.55-₹8.18
Tax₹0.00₹0.18₹0.03₹0.00
Profit After Tax₹5.81₹3.05₹1.53-₹8.18
EPS - Basic₹1.97₹1.14₹0.58-₹3.32
EPS - Diluted₹1.97₹1.14₹0.58-₹3.32

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹5.81₹3.23₹1.55-₹8.18
Income before WC changes₹7.45₹4.64₹3.08-₹5.43
Change in Assets₹2.51-₹1.71-₹3.78₹9.54
Change in Liabilities-₹0.73-₹0.81-₹9.29-₹3.37
Change in WC₹1.78-₹2.52-₹13.08₹6.17
Cash flow from Operations₹9.29₹2.63-₹9.80₹0.55
Cash flow from Investing-₹2.92-₹45.14₹0.18-₹0.40
Cash flow from Financing₹0.17₹42.43₹9.72-₹0.21
Total Cash Flow₹6.54-₹0.08₹0.10-₹0.06
Cash (Start of the year)₹0.04₹0.13₹0.02₹0.08
Cash (End of the year)₹6.59₹0.04₹0.13₹0.02

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹108.95₹106.78₹63.34₹64.82
Current Assets₹37.42₹33.88₹31.05₹27.61
Total Assets₹146.36₹140.66₹94.39₹92.42
Current Liabilities₹21.81₹22.84₹23.05₹33.02
Net Current Asset₹15.60₹11.03₹8.00-₹5.42
Non-Current Liabilities₹3.70₹2.75₹1.81₹2.62
Equity Capital₹120.84₹115.07₹69.53₹56.78
Total Equity & Liabilities₹146.36₹140.66₹94.39₹92.42
* All values are in INR Crore
Qty
Bid
5
60.82
73
60.77
7
60.54
10
60.02
10
60
Ask
Qty
60.87
20
60.88
6
60.9
27
60.92
29
60.95
29
Bid Total: 105
Ask Total: 111
Buy orders: 49%
Sell orders: 51%
Bearish
1
Neutral
2
Bullish
5
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
39.65
Neutral
ATR (14)
4.18
Neutral
STOCH(9,6)
7.57
Bullish
STOCH RSI (14)
0
Bullish
ADX(9)
19.41
Bullish
UO(9)
29.98
Bullish
ROC(12)
-7.89
Bearish
WillR(14)
-93.08
Bullish
Period
Simple value
Exponential vaue
5D
60.39
60.46
10D
62.09
61.7
20D
63.84
62.61
50D
63.31
63.47
100D
63.09
63.86
Volume trend — traded volume by day
23 Sep0L
22 Sep0L
21 Sep0L
18 Sep0L
17 Sep0L
16 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
BROOKS LABORATORIES Share Price
BROOKS LABORATORIES
Pharmaceuticals
Add Stock
Add Another

BROOKS LABORATORIES Share Price FAQs

BROOKS LABORATORIES share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837